Oncolytics Biotech, Inc. (ONCY)

0.663 -0.02 (-2.97%) USD  |  NASDAQ  |  Sep 28, 16:00
0.6643 0.00 (0.00%) Pre-Market: 08:53
More

Oncolytics Biotech Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for ONCY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to 2000. Start Trial.
Date Value
December 31, 2000 --

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Anixa Biosciences, Inc. --
Vicapsys Life Sciences, Inc. --